Drug discontinuation: Tiagabine Hydrochloride Tablet (TIAGABINE HYDROCHLORIDE)
FDA lists 4 presentations as To Be Discontinued. Companies: Teva Pharmaceuticals USA, Inc..
- Published by source
- 2026-04-15
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Products
- Tiagabine Hydrochloride Tablet TIAGABINE HYDROCHLORIDE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-04-15
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #1030 | new | 2026-10-22 | 2e88fa92ffc1…7ee9bf | 09f93d78396d…2f52d9 |
Chain head: #1076 8ad5adc30b9b…88ce20